info@pdci.ca
Newsletter Sign-Up
Login to PDCI Services
Contact Us
Navigation
Home
About
About Us
Our Team
Careers
Services
News & Events
Publications
What’s New
Home
What’s New
30
Mar
2016
Minimum Period of 120 Calendar Days for Advance Notification of Anticipated Submissions and Resubmissions for CADTH’s CDR and pCODR Programs
March 30, 2016
Recommendation Framework for CADTH Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) Programs In collaboration with the participating jurisdictions ...
Read More
24
Mar
2016
The PMPRB to Implement Next Steps Regarding the Compendium of Policies, Guidelines and Procedures in June 2016
March 24, 2016
In December 2015, the Patented Medicine Prices Review Board (PMPRB) posted a Notice and Comment seeking stakeholder comments on ...
Read More
24
Mar
2016
Ontario’s CED Will No Longer Routinely Evaluate CDR- or pCODR-Reviewed Drug Products
March 24, 2016
Effective April 1, 2016, all drug products reviewed by the Common Drug Review (CDR) and the pan-Canadian Oncology Drug Review ...
Read More
15
Mar
2016
Ontario Public Drug Programs Funds INFLECTRA™ (infliximab)
March 15, 2016
The Ontario Public Drug Programs (OPDP) began funding INFLECTRA™ (infliximab) as a Limited Use (LU) benefit for eligible ODB recipients, ...
Read More
Previous
1
...
63
64
65
66
67
68
69
...
93
Next